GME
65
3
IP
33
3
ALL
51
7
CRM
49
5
PPG
64
3
MPC
52
10
TDC
67
2
PHM
71
2
FSLR
60
5
IR
83
3
C
46
2
VLO
33
-2
WRK
59
3
DO
58
6
CF
27
-12
TRIP
75
9
MTCH
50
2
L
50
-5
AEE
41
-4
HOG
33
6
GME
65
3
IP
33
3
ALL
51
7
CRM
49
5
PPG
64
3
MPC
52
10
TDC
67
2
PHM
71
2
FSLR
60
5
IR
83
3
C
46
2
VLO
33
-2
WRK
59
3
DO
58
6
CF
27
-12
TRIP
75
9
MTCH
50
2
L
50
-5
AEE
41
-4
HOG
33
6
Financhill
Back

Hepion Pharmaceuticals Quote, Financials, Valuation and Earnings

9,530x the last time this happened

Here's what our expert says you should buy before April 14.
Sell
8

HEPA
Hepion Pharmaceuticals

Last Price:
1.40
Seasonality Move:
-2.75%

7 Day Trial

ALL ACCESS PASS

$ 7

Master the Market: The Formula for a 96.3% Win Rate Revealed!

Act now!

Hepion Pharmaceuticals Price Quote

$1.40
+0.03 (+8.53%)
(Updated: April 27, 2024 at 6:07 AM ET)

Hepion Pharmaceuticals Key Stats

Sell
8
Hepion Pharmaceuticals (HEPA) is a Sell
Day range:
$1.27 - $1.44
52-week range:
$1.22 - $20.66
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.34%
Volume:
39.6K
Avg. volume:
46.7K
1-year change:
-89.93%
Market cap:
$7.5M
Revenue:
$0
EPS:
$-12.32

How Much Does Hepion Pharmaceuticals Make?

Data Unavailable

Is Hepion Pharmaceuticals Growing As A Company?

Data Unavailable

Hepion Pharmaceuticals Stock Price Performance

What Is Hepion Pharmaceuticals 52-Week High & Low?

Hepion Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Hepion Pharmaceuticals?

Is Hepion Pharmaceuticals Cash Flow Positive?

  • What Is HEPA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$40.9M
  • What Is Hepion Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $4.5M
  • What Is Hepion Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$14.3K

Hepion Pharmaceuticals Return On Invested Capital

Data Unavailable

Hepion Pharmaceuticals Earnings Date & Stock Price

Hepion Pharmaceuticals Competitors

Hepion Pharmaceuticals Dividend Yield

Data Unavailable

Hepion Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 30.00
Upside from Last Price: 2089.78%

Major Shareholders

  • How many HEPA shares are owned by institutional investors?
    1M HEPA shares are owned by institutional investors
  • How many HEPA shares are owned by insiders?
    723.5K HEPA shares are owned by insiders